JanOne is a biotechnology company dedicated to developing treatments for diseases that cause severe pain, with a focus on reducing the need for opioid prescriptions. Their current focus is on peripheral artery disease (PAD), a condition affecting millions of Americans, aiming to provide non-addictive solutions for pain relief.
Through their research and development efforts, JanOne is working towards treating pain at its source and advancing potential non-addictive pain solutions. With promising clinical trial results for their PAD treatment, the company is committed to making strides in addressing the opioid crisis and improving pain management options.
Generated from the website